Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months

Lepr Rev. 1975 Jun;46(2 Suppl):169-72. doi: 10.5935/0305-7518.19750061.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Clinical Trials as Topic
  • Dapsone / therapeutic use*
  • Drug Combinations
  • Drug Therapy, Combination
  • Humans
  • Isoniazid / therapeutic use*
  • Isonicotinic Acids / therapeutic use*
  • Leprostatic Agents / pharmacology
  • Leprostatic Agents / therapeutic use*
  • Leprosy / drug therapy*
  • Leprosy / microbiology
  • Mycobacterium leprae / drug effects
  • Prothionamide / therapeutic use*
  • Rifampin / pharmacology
  • Rifampin / therapeutic use*

Substances

  • Drug Combinations
  • Isonicotinic Acids
  • Leprostatic Agents
  • Prothionamide
  • Dapsone
  • Isoniazid
  • Rifampin